HealthDay News -- Using a faster and more efficient method of reprogramming adult stem cells to an embryonic stem cell-like state, Johns Hopkins researchers developed a human stem cell line containing the mutation associated with sickle cell anemia.
HealthDay News -- Using a faster and more efficient method of reprogramming adult stem cells to an embryonic stem cell-like state, Johns Hopkins researchers developed a human stem cell line containing the mutation associated with sickle cell anemia.